3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Unknown
2
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Classical hematology
1
Conditions
Neoplasms
2
Non-hematological Malignancies
1
Anemia, Iron-Deficiency
1
Anemia
1
Interventions
Epoetin Alfa
43
Darbepoetin alfa
33
epoetin beta
10
ferric carboxymaltose
6
Cyclosporine
4
Cisplatin
4
ferrous sulfate
3
Radiotherapy
3
Lenalidomide
3
peginesatide
2
luspatercept
2
hematide
2
fludarabine
2
ferric gluconate
2
continuous erythropoietin receptor activator
2
Therapeutics
2
Filgrastim
2
Erythropoietin
2
Dexamethasone
2
Cyclophosphamide
2
Brachytherapy
2
Antilymphocyte Serum
2
ACE-011
2
thymoglobulin
1
ruxolitinib
1
roxadustat
1
reolysin
1
pegfilgrastim
1
obinutuzumab
1
leridistim
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Anemia
×
iron isomaltoside 1000
×
Clear all
NCT01280240
2013-06-04
PK-CIA-06
Pharmacosmos A/S
Phase 1
Completed
11 enrolled